Table 5. Total proportion of recurrences or deaths of R any patients base on the IASLC/ITMIG TNM staging proposal.
| Stage | Recurrences |
Deaths |
|||
|---|---|---|---|---|---|
| % | N | % | N | ||
| I | 4 | 36/870 | 2 | 17/886 | |
| T1aN0M0 | 4 | 30/798 | 1 | 12/814 | |
| T1bN0M0 | 8 | 6/72 | 7 | 5/72 | |
| II | 13 | 6/47 | 2 | 1/48 | |
| III | 19 | 38/195 | 5 | 11/205 | |
| IIIa | 18 | 32/178 | 4 | 7/188 | |
| IIIb | 35 | 6/17 | 24 | 4/17 | |
| IVa | 39 | 15/38 | 13 | 5/38 | |
| TxN1M0 | 43 | 6/14 | 29 | 4/14 | |
| TxN0M1a | 36 | 8/22 | 5 | 1/22 | |
| TxN1M1a | 50 | 1/2 | 0 | 0/2 | |
| IVb | 24 | 5/21 | 24 | 5/21 | |
| TxN2M0,1a | 33 | 2/6 | 33 | 2/6 | |
| TxN0–2M1b | 20 | 3/15 | 20 | 3/15 | |
| Total | 9 | 100/1,171 | 3 | 39/1,198 | |
IASLC, the International Association for the Study of Lung Cancer; ITMIG, the International Thymic Malignancies Interest Group.